Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Cariou

Showing results (121-130 of 311) with videos related to

Pageof 32
Sort By:
International Journal of Surgery (London, England)|March 14, 2023
Parathyroidectomy for primary hyperparathyroidism: effect on quality of life after 3 years - a prospective cohort studySamuel Frey, Bastien Perrot, Cécile Caillard, et al.
The Journal of Biological Chemistry|January 13, 2006
Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1cPhilippe Costet, Bertrand Cariou, Gilles Lambert, et al.
The Lancet. Diabetes & Endocrinology|March 28, 2017
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trialVanita R Aroda, Stephen C Bain, Bertrand Cariou, et al.
Diabetes, Obesity & Metabolism|October 18, 2021
Influenza vaccination and prognosis for COVID-19 in hospitalized patients with diabetes: Results from the CORONADO studyAlhassane Diallo, Matthieu Pichelin, Matthieu Wargny, et al.
FEBS Letters|July 30, 2003
Inhibition of FGF receptor signalling in Xenopus oocytes: differential effect of Grb7, Grb10 and Grb14Katia Cailliau, Véronique Le Marcis, Véronique Béréziat, et al.
Archives of Medical Science : AMS|March 23, 2022
Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISEMaciej Banach, José Luis López-Sendon, Maurizio Averna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 2021
Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial HypercholesterolemiaMartine Paquette, Sophie Bernard, Bertrand Cariou, et al.
Circulation Research|November 13, 2004
Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation propertiesElisabeth Teissier, Atsushi Nohara, Giulia Chinetti, et al.
Diabetes & Vascular Disease Research|September 13, 2014
The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effectsRémy Hanf, Lesley J Millatt, Bertrand Cariou, et al.
Journal of Clinical Lipidology|April 1, 2023
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemiaMartine Paquette, Sophie Bernard, Bertrand Cariou, et al.
Pageof 32

Showing results (121-130 of 311) with videos related to

Sort By:
Pageof 32
International Journal of Surgery (London, England)|March 14, 2023
Parathyroidectomy for primary hyperparathyroidism: effect on quality of life after 3 years - a prospective cohort studySamuel Frey, Bastien Perrot, Cécile Caillard, et al.
The Journal of Biological Chemistry|January 13, 2006
Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1cPhilippe Costet, Bertrand Cariou, Gilles Lambert, et al.
The Lancet. Diabetes & Endocrinology|March 28, 2017
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trialVanita R Aroda, Stephen C Bain, Bertrand Cariou, et al.
Diabetes, Obesity & Metabolism|October 18, 2021
Influenza vaccination and prognosis for COVID-19 in hospitalized patients with diabetes: Results from the CORONADO studyAlhassane Diallo, Matthieu Pichelin, Matthieu Wargny, et al.
FEBS Letters|July 30, 2003
Inhibition of FGF receptor signalling in Xenopus oocytes: differential effect of Grb7, Grb10 and Grb14Katia Cailliau, Véronique Le Marcis, Véronique Béréziat, et al.
Archives of Medical Science : AMS|March 23, 2022
Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISEMaciej Banach, José Luis López-Sendon, Maurizio Averna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 2021
Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial HypercholesterolemiaMartine Paquette, Sophie Bernard, Bertrand Cariou, et al.
Circulation Research|November 13, 2004
Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation propertiesElisabeth Teissier, Atsushi Nohara, Giulia Chinetti, et al.
Diabetes & Vascular Disease Research|September 13, 2014
The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effectsRémy Hanf, Lesley J Millatt, Bertrand Cariou, et al.
Journal of Clinical Lipidology|April 1, 2023
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemiaMartine Paquette, Sophie Bernard, Bertrand Cariou, et al.
Pageof 32